Development of Novel Therapies for NIDDM

NCT01905722 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Metabolism

Interventions

OTHER: 3 Tesla
OTHER: 7 Tesla

Sponsor

Duke University

Collaborators

[object Object]
[object Object]